Takeda New Frontier Science (NFS) aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients' lives.
There have been multiple attempts by healthcare companies to develop early-stage ideas from academia and entrepreneurs into the next blockbuster product but the challenges to success remain severe. Into this (mine)field is stepping Japan-based drugs company Takeda Pharmaceuticals, which could launch its early-stage development initiative as early as next month. Takeda New Frontier Science (NFS)…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
